Can Radiotherapy Cause Bronchiectasis?
Yes, radiotherapy can cause bronchiectasis as a manifestation of radiation-induced lung injury, typically appearing as traction bronchiectasis within the radiation field during the late fibrotic phase (>6 months post-treatment).
Understanding Radiation-Induced Bronchiectasis
Radiotherapy-induced bronchiectasis occurs through a specific pathophysiological mechanism distinct from other causes of bronchiectasis. The radiation damage triggers a cascade of injury to type I pneumocytes, leading to chronic inflammation, microvascular changes, and ultimately fibrosis with associated traction on the airways 1, 2, 3.
Timeline and Radiological Features
The development follows a predictable temporal pattern:
- Acute phase (during treatment to 2-6 months): Ground-glass opacities and consolidation predominate, representing radiation pneumonitis 4, 3
- Late phase (>6 months): Traction bronchiectasis emerges alongside volume loss, consolidation, and scarring as radiation fibrosis develops 2, 3
Traction bronchiectasis is present in approximately 37-52% of patients at 12 months post-radiation and represents one of the characteristic late findings of radiation-induced lung damage 1.
Key Distinguishing Features
Radiation-induced bronchiectasis has specific characteristics that differentiate it from other causes 5:
- Location: Confined to the radiation portal/field, not following typical anatomical distributions seen in infectious or genetic bronchiectasis
- Pattern: Associated with volume loss, fibrosis, and architectural distortion within the treated area
- Mechanism: Results from traction forces on airways from surrounding fibrotic lung parenchyma, not from the infectious/inflammatory cycle described in the "vicious vortex" of primary bronchiectasis 6
Clinical Implications
This is traction bronchiectasis secondary to fibrosis, not the chronic suppurative bronchiectasis that requires the management strategies outlined in bronchiectasis guidelines 6. The 2025 ERS guidelines specifically address bronchiectasis caused by infectious, autoimmune, allergic, and genetic disorders—radiation-induced traction bronchiectasis represents a fundamentally different pathophysiological entity 6.
Important Diagnostic Caveat
Filling in of previously patent radiation-induced ectatic bronchi is a reliable sign of locally recurrent lung cancer 7. In one study, this finding occurred in all 20 patients with recurrent disease and was the first sign of recurrence in 30% of cases. Therefore, any change in previously stable radiation-induced bronchiectasis warrants immediate investigation for malignancy recurrence.
Management Considerations
The pathophysiology resembles adult bronchiectasis with pro-angiogenic and pro-fibrogenic stimuli, continuing inflammation, and microvascular changes 8. However, treatment focuses on:
- General supportive management
- Mobilization of airway secretions
- Anti-inflammatory therapy (corticosteroids for acute pneumonitis)
- Management of acute exacerbations
- Monitoring for disease progression and recurrence 4, 8
The standard long-term antibiotic and mucoactive therapies recommended for primary bronchiectasis are not routinely indicated for radiation-induced traction bronchiectasis unless secondary infection develops 6.